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Neutrophils contain four uncharacterized protein kinases with molecular masses of ca. 69, 63, 49 and 40 kDa that are rapidly activated upon 
stimulation of these cells with the chemoattractant fMet-Leu-Phe [Ding, J. and Badwey, J.A . (1993) J. Biol. Chem. 268,1732617333]. We now report 
that wortmannin and I-butanol block activation of all four of these kinases. These reagents are known to inhibit superoxide generation in neutrophils 
stimulated with this agonist. Wortmannin inhibits phosphatidylinositol3-kinase and blocks activation of phospholipase D, whereas I-butanol can 
reduce the generation of phosphatidate in cells by serving as a substrate for phospholipase D. These data suggest hat phosphatidylinositol3-kinase 
and phospholipase D may be involved in the activation of several novel protein kinases in neutrophils and that one or more of these kinases is/are 
involved in superoxide release. 
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1. Introduction 
Neutrophils stimulated with the chemoattractant 
fMLP display a variety of phenomena that include shape 
changes, chemotaxis, degranulation and the production 
of large quantities of 0; (for review, see [ 11). Cells treated 
with this agonist also exhibit rapid activation of several 
uncharacterized protein kinases with molecular masses 
of ca. 69, 63, 49 and 40 kDa [2-51. These kinases can be 
detected by a procedure based on their ability to undergo 
renaturation and autophosphorylation in a gel, or to 
catalyze the phosphorylation of a peptide or protein sub- 
strate fixed in the gel [3-51. The novel 69, 63, 49 and 40 
kDa kinases are not activated when neutrophils are stim- 
ulated with calcium ionophores, activators of protein 
kinase C (e.g. PMA), or the combination of these agents 
(e.g, [3,4,6]). Activation of these kinases was blocked by 
treating the cells with pertussis toxin, which indicates a 
role for a heterotrimeric G-protein in this response [46]_ 
Previous studies have shown that the microbial metab- 
olite wortmannin blocks a signal transduction sequence 
in fMLP-stimulated neutrophils that is necessary for 
degranulation and 0; production [7,8]. This signal is 
dependent upon a heterotrimeric G-protein but inde- 
pendent of Ca2+ [8]. Wortmannin has recently attracted 
considerable interest since it directly inhibits PI 3-kinase 
[9-l l] and blocks activation of phospholipase D in neu- 
trophils [12-141. Primary alcohols also block degranula- 
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12-myristate 13-acetate, p47-phox, the 47 kDa protein component of 
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tion and 0; release in cells stimulated with fMLP but not 
PMA [15-171. In this communication, we describe the 
effects of wortmannin and 1-butanol on the activation of 
the 69, 63, 49 and 40 kDa protein kinases. 
2. Materials and methods 
2.1. Materials 
Wortmannin was purchased from Kamiya Biomedical Company, 
Thousand Oaks, CA. Isomers of butanol were obtained from Fischer 
Scientific, PA. Sources of all other materials are provided elsewhere 
]3,41. 
2.2. Preparation of neutrophils 
Guinea pig peritoneal neutrophils were prepared as described previ- 
ously [18]. 
2.3. Superoxide release and preparation of solubilized neutrophils for 
assaying the renaturable protein kinases 
These procedures are described in detail in [19] and [3], respectively. 
2.4. Detection of renaturable protein kinases in polyacrylamide gels 
In this procedure, protein kinases are detected irectly in gels by their 
ability to undergo renaturation and catalyze the phosphorylation of a 
peptide substrate that corresponds to amino acid residues 297 to 331 
of p47-phox ‘fixed’ in the gel. This technique is presented in [4]. 
2.5. Analysts of data 
Unless otherwise noted, all of the autoradiographic observations 
were confirmed in at least three separate experiments performed on 
different preparations of cells. The number of observations (n) are also 
based on different preparations of cells. 
3. Results 
3. I. Effects of wortmannin on guinea pig neutrophils 
Neutrophils stimulated with 1.0 PM fMLP release 0; 
at a rate of ca. 45 nmol O;/min/lO’ cells (e.g. [4]). This 
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Fig. 1. Effects of wortmannin on superoxide release by neutrophils. 
Reaction progress curves demonstrate the effects of wortmannin on the 
release of 0; from neutrophils stimulated with 1 .O ,uM fMLP. Cells were 
incubated with wortmannin for 5 min prior to the addition of fMLP, 
which was added last to initiate the reactions (solid arrow). The concen- 
trations of wortmannin were: (a) 0 nM (control); (b) 10 nM; 
(c) 50 nM; (d) 100 nM; and (e) 1.0 PM. Addition of 50 nM PMA to 
neutrophils previously treated with 1.0 PM wortmannin and fMLP 
(broken arrow) resulted in the restimulation of 0; release (curve g, 
dotted line). Curve f is for unstimulated cells. The inset shows the 
dose-response curve for wortmannin in inhibiting 0; release. These data 
represent the mean% inhibition f S.D. from four separate experiments 
performed on different cell preparations. 
response was immediate and transient with the majority 
of the event occurring in the first 3 min (Fig. 1, curve a). 
Treatment of the cells with wortmannin for 5 min prior 
to stimulation with 1.0 PM fMLP resulted in a dose- 
dependent inhibition of 0; release. Half-maximal inhibi- 
tion occured at 46 + 18 nM (S.D., n = 4) wortmannin 
(Fig. 1, inset). In contrast, 1.0 PM wortmannin did 
not block 0; release from cells stimulated with PMA 
J. Ding, J.A. BadweylFEBS Letters 348 (1994) 149-152 
(e.g. Fig. 1, curve g). Wortmannin (1.0 PM) inhibited 0; 
release from neutrophils stimulated with 1.0 PM fMLP 
or 50 nM PMA by 81 f 8% and 8 + 8% (SD., n = 6-7), 
respectively. Similar observations have been published 
previously for human neutrophils [7,8]. 
Neutrophils stimulated with fMLP exhibit a rapid ac- 
tivation of four renaturable protein kinases with molecu- 
lar masses of ca. 69, 63, 49 and 40 kDa. These kinases 
can catalyze the phosphorylation of a peptide substrate 
that corresponds to amino acid residues 297 to 331 of 
p47-phox [4] (Fig. 2, part A). This peptide contains sev- 
eral of the potential phosphorylation sites of the com- 
plete p47-phox protein (e.g. serines 303, 304, 315, 320 
and 325) [20]. All four of these kinases exhibited maximal 
activity within 15 s of the addition of the stimulus fol- 
lowed by significant inactivation at 3 min. The kinetics 
of the activation of these kinases was similar to the kinet- 
ics of phosphorylation of p47-phox and 0; release in 
intact neutrophils stimulated with fMLP [4] (Fig. 1, 
curve a). A 96 kDa protein kinase was also activated at 
time periods 2 1 min. Wortmannin (100 nM) blocked 
activation of the 69, 63, 49 and 40 kDa protein kinases 
(Fig. 2, part B). The time-course of inhibition was very 
similar for each of these kinases. Partial inhibition oc- 
curred at 50 nM and 25 nM wortmannin, whereas 10 nM 
was largely without effect. For example, the percent inhi- 
bition of the 63 kDa protein kinase in cells treated with 
1.0 ,uM, 100 nM and 10 nM wortmannin for 5 min and 
then stimulated with fMLP for 1 min was estimated by 
densitometry at 81 * 9% (SD., n = 5), 76 ? 12% (SD., 
n = 3) and 17 ? 22% (S.D., n = 3), respectively. Wort- 
mannin did not block the activation of the 96 kDa kinase 
nor did it effect the renaturable protein kinases in un- 
stimulated cells (Fig. 2, part B). 
3.2. Effects of butanol on neutrophils 
The effects of different isomers of butanol on the re- 
lease 0; from stimulated neutrophils are presented in Fig. 
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Fig. 2. Effects of wortmannin on the activation of the renaturable protein kinases that catalyze phosphorylation of the p47-phox peptide. Neutrophils 
were incubated in the absence (A) and presence of 0.10 ,uM wortmannin (B) for 5 min prior to stimulation with 1 .O ,uM WLP. The cells were treated 
with: (a) 0.25% (v/v) dimethyl sulfoxide for 15 s (unstimulated cells); (b) fMLP for 15 s; (c) fMLP for 30 s; (d) fMLP for 1 min; (e) fMLP for 3 mitt; 
and (ft 0.25% (v/v) dimethyl sulfoxide for 3 min. The positions of the 63 and 40 kDa kinases are designated by unbroken arrows, whereas the 69 
and 49 kDa kinases are marked by arrowheads. Molecular mass markers are provided on the left. 
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Fig. 3. Effects of different isomers of butanol on superoxide release by 
neutrophils. Reaction progress curves demonstrate the effects of the 
isomers of butanol on superoxide release by neutrophils. Cells were 
incubated with the alcohols (55 mM) for 5 min prior to the addition of 
1.0 PM WLP, which was added last to initiate the reactions (solid 
arrow). The curves shown were from stimulated cells: (a) not treated 
with an isomer of butanol; (b) treated with tert-butanol; (c) treated with 
2-butanol; and (d) treated with I-butanol. Curve e is for unstimulated 
cells. Addition of 50 nM PMA (broken arrow) to neutrophils previously 
treated with 55 mM 1-butanol and fMLP resulted in the restimulation 
of 0; release (curve f, dotted line). The inset shows the dose-response 
curves for 1-butanol in inhibiting 0; release from cells stimulated with 
1.0 ,uM fMLP (0) or 50 nM PMA (0). The error bars at 55 mM 
1-butanol represent he mean% inhibition f S.D. from 7 separate x- 
periments. 
3. 1-Butanol, 2-butanol and tert-butanol at concentra- 
tions of 55 mM inhibited 0; release from cells stimulated 
with 1.0 ,uM fMLP by 74 f 2%, 20 f 5% and 7 f 3% 
(S.D., n = 4) respectively. In contrast, 1-butanol (55 
mM) inhibited 0; release from cells stimulated with 50 
nM PMA by 27 * 7% (SD., n = 8). 1-Butanol also 
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blocked the activation of the 69, 63, 49 and 40 kDa 
protein kinases with similar kinetics (Fig. 4, Part B). As 
was the case with wortmannin, this inhibition was most 
pronounced at time periods 2 30 s. A previous study has 
provided evidence for early and late phases of phosphat- 
idate production in fMLP-stimulated neutrophils, with 
only the late pool generated by phospholipase D being 
functionally linked to 0; generation [14]. Unlike wort- 
mannin, 1-butanol also partially blocked the activation 
of the 96 kDa kinase (Fig. 4, part B, lanes e and f). In 
contrast, 2-butanol and tert-butanol were not as effective 
as 1-butanol in blocking the activation of these enzymes. 
For example, the percent inhibition of the 63 kDa pro- 
tein kinase in cells treated with l-, 2- and tert-butanol(55 
mM) for 5 min and then stimulated with fMLP for 1 min 
was estimated by densitometry at 77 f 8%, 39 * 4% and 
24 f 1% (SD., n = 3), respectively. 
Addition of 1 .O ,uM wortmannin or 55 mM 1 -butanol 
to the assay mixture employed to detect the renaturable 
protein kinases in the gel did not affect the activity of 
these enzymes. This suggests that these reagents did not 
interact with the 69, 63, 49 and 40 kDa kinases them- 
selves but on upstream components that are involved in 
the activation of these enzymes. Finally, wortmannin 
(1 .O PM) and 1-butanol did not affect the viability of 
neutrophils (as measured by exclusion of trypan blue) 
nor did these reagents cavange 0; in a cell-free system 
(i.e. xanthine oxidase plus purine). 
4. Discussion 
In this communication, we report that wortmannin 
and 1-butanol block activation of a novel family of pro- 
tein kinases in neutrophils. As noted above, wortmannin 
directly inhibits PI 3-kinase [9-l l] and blocks activation 
of phospholipase D in these cells [12-141. In contrast, 
1-butanol can directly inhibit protein kinase C [21] and 
1 
Fig. 4. Effects of I-butanol on the activation of the renaturable protein kinases that catalyze phosphorylation of the p47-phox peptide. Neutrophils 
were incubated in the absence (A) and presence of 55 mM l- butanol (B) for 5 min prior to stimulation with 1.0 PM WLP. The cells were treated 
with: (a) 0.25% (v/v) dimethyl sulfoxide for 15 s (unstimulated cells); (b) fMLP for 15 s; (c) fMLP for 30 s; (d) fMLP for 1 min; (e) fMLP for 3 min; 
and (f) 0.25% (v/v) dimethyl sulfoxide for 3 min. The positions of the 63 and 40 kDa kinases are designated by unbroken arrows, whereas the 69 
and 49 kDa kinases are marked by arrowheads. Molecular mass markers are provided on the left. 
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may inhibit phosphatidate production (along with 
diglyceride) by serving as a substrate in the phospholip- 
ase D reaction (e.g. [17]). PI 3-kinase and phospholipase 
D are involved in the production of increased amounts 
of phosphatidylinositol 3,4,5trisphosphate and diglyc- 
eride in fMLP-stimulated neutrophils (e.g. [ 14,22,23]). 
These compounds selectively activate the /I and I- 
isozymes of protein kinase C, respectively (e.g. [24,25]). 
Both of these species of protein kinase C are present in 
neutrophils (e.g. [26,27]). The concentrations of wort- 
manin that inhibit PI 3-kinase in neutrophils (I&, = 50 
nM) [lo] are very similar to those that block both 0; 
release (IC,, = 46 + 18 nM; Fig. 1) and the activation of 
the 69,63,49 and 40 kDa protein kinases (Fig. 2). Wort- 
mannin inhibits PI 3-kinase from myeloid cells activated 
in vitro by either the /3y subunits of heterotrimeric 
G-proteins or by a tyrosine phosphorylated peptide at 
saturating ATP (2.0 mM) with IC,, values of 43 nM and 
17 nM, respectively [ll]. It is interesting to note in this 
context that the c-isozyme of protein kinase C is insensi- 
tive to phorbol esters (e.g. [24]) and that neutrophils 
treated with PMA do not exhibit activation of the 69,63, 
49 and 40 kDa protein kinases [3-51. In fact, neutrophils 
treated with PMA exhibit a decrease in the basal activi- 
ties of these enzymes [3,4]. Thus, PI 3-kinase, phospho- 
lipase D and/or an isozyme of protein kinase C that is 
insensitive to PMA may be involved in the stimulatory 
pathway which triggers activation of these novel protein 
kinases. 
As noted earlier, wortmannin and 1 -butanol inhibit 0; 
generation and degranulation in neutrophils stimulated 
with fMLP but not PMA [8,15-171. These reagents 
should therefore be useful not only in sorting out the 
biochemical events involved in the activation of these 
kinases, but also in defining their physiological sub- 
strates and functions. 
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